In a recent filing, Patrick Williams, President and CEO of Innospec Inc., disclosed a transaction involving 22,203 shares of phantom stock. This transaction, reported on October 5, 2026, is noteworthy as it underscores the company's approach to executive compensation and performance alignment.
Innospec Inc. operates in the chemicals industry, focusing on industrial applications and services. The company is incorporated in Delaware and has a fiscal year ending on December 31. The recent filing is part of a series of disclosures, with the latest being on October 8, 2026, also a Form 4.
The filing details that the transaction occurred on October 1, 2026, and that the phantom stock is equivalent to common stock shares of Innospec. Williams's ownership following this transaction stands at 22,203 shares. The filing also notes that the award will vest in stages, with 25% vesting on February 1, 2027, and another 25% on October 1, 2027, with the remaining 50% vesting on October 1, 2028.
This update may affect various stakeholders, including shareholders and employees, as it reflects Innospec's commitment to aligning executive compensation with company performance. Such moves can influence perceptions of leadership effectiveness and corporate governance.
Details were not available in the SEC filing regarding any upcoming events or further actions related to this transaction.